ALPA Alpha Healthcare Acquisition Corp. III

Alpha Healthcare Acquisition Corp. III

Medical/Dental Instruments

Health Care

Alpha Healthcare Acquisition Corp. III focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.

IPO Year: 2021

Exchange: NASDAQ

Recent Analyst Ratings for Alpha Healthcare Acquisition Corp. III

Date	Price Target	Rating	Analyst

See more ratings

Alpha Healthcare Acquisition Corp. III Press Releases

Fastest customizable press release news feed in the world

View All

Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation

Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) ("ALPA"), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the successful completion of its business combination (the "Business Combination") with Carmell Therapeutics Corporation, a Phase 2 stage regenerative medicine platform company developing allogeneic plasma-based biomaterials for active soft tissue repair, aesthetics and orthopedic indications ("Carmell"). The resulting combined company, Carmell Therapeutics Corporation, is expected to commence trading of its shares of common stock and warrants on the Nasdaq Capital Market® under the ticker symbols "CTCX" and "CTCXW," respectively, on July 17, 2023.

7/14/23 3:12:00 PM ET

$ALPA

Medical/Dental Instruments

Health Care

Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination

Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) ("ALPA"), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the execution of a non-binding letter of intent (the "LOI") to acquire a commercial stage regenerative medicine company (the "Target") conditioned upon the closing of ALPA's initial business combination with Carmell Therapeutics Corporation, a Phase 2 stage regenerative medicine platform company developing allogeneic plasma-based biomaterials for active soft tissue repair, aesthetics and orthopedic indications ("Carmell"). ALPA has set a Stockholders Meeting (the "Meeting") to consider the previously announced business combination with Carmell for J

6/27/23 7:00:00 AM ET

$ALPA

Medical/Dental Instruments

Health Care

Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft Tissue Healing Indications

Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) ("ALPA"), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the execution of a definitive business combination agreement with Carmell Therapeutics Corporation ("Carmell™"), a Phase 2-stage biotechnology platform company developing allogeneic plasma-based biomaterials for bone and soft tissue healing indications. Upon closing of the transaction, ALPA will be renamed Carmell Therapeutics Corporation (the "Combined Company"). Mr. Shukla will serve as Chairman and Mr. Randy Hubbell will serve as Chief Executive Officer of the Combined Company. The Combined Company's common stock is expected to be listed on the Na

1/4/23 10:11:00 PM ET

$ALPA

Medical/Dental Instruments

Health Care

Alpha Healthcare Acquisition Corp. III

Recent Analyst Ratings for Alpha Healthcare Acquisition Corp. III

Alpha Healthcare Acquisition Corp. III

Recent Analyst Ratings for Alpha Healthcare Acquisition Corp. III

Alpha Healthcare Acquisition Corp. III Insider Purchases

Cassaday Bryan J. bought $1,540 worth of shares (440 units at $3.50), increasing direct ownership by 29% to 1,940 units (SEC Form 4)

Spenlehauer Gilles bought $3,456 worth of shares (904 units at $3.82) (SEC Form 4)

Frisch Scott M. bought $3,456 worth of shares (904 units at $3.82) (SEC Form 4)

Sturgeon Patrick A bought $4,320 worth of shares (1,130 units at $3.82) (SEC Form 4)

Gregory Kathryn bought $4,320 worth of shares (1,130 units at $3.82) and acquired 0 shares (SEC Form 4)

Anderson David W bought $4,320 worth of shares (1,130 units at $3.82) and acquired 0 shares (SEC Form 4)

Upton Richard A bought $15,330 worth of shares (4,400 units at $3.48) and acquired 0 shares (SEC Form 4)

Sturgeon Patrick A bought $13,696 worth of shares (3,261 units at $4.20) (SEC Form 4)

Frisch Scott M. bought $10,953 worth of shares (2,608 units at $4.20) (SEC Form 4)

Spenlehauer Gilles bought $10,953 worth of shares (2,608 units at $4.20) (SEC Form 4)

Alpha Healthcare Acquisition Corp. III Insider Trading

Shukla Rajiv was granted 14,347 shares and acquired 0 shares, increasing direct ownership by 42% to 48,526 units (SEC Form 4)

Cassaday Bryan J. bought $1,540 worth of shares (440 units at $3.50), increasing direct ownership by 29% to 1,940 units (SEC Form 4)

Spenlehauer Gilles bought $3,456 worth of shares (904 units at $3.82) (SEC Form 4)

Frisch Scott M. bought $3,456 worth of shares (904 units at $3.82) (SEC Form 4)

Sturgeon Patrick A bought $4,320 worth of shares (1,130 units at $3.82) (SEC Form 4)

Gregory Kathryn bought $4,320 worth of shares (1,130 units at $3.82) and acquired 0 shares (SEC Form 4)

Anderson David W bought $4,320 worth of shares (1,130 units at $3.82) and acquired 0 shares (SEC Form 4)

Upton Richard A bought $15,330 worth of shares (4,400 units at $3.48) and acquired 0 shares (SEC Form 4)

Sturgeon Patrick A bought $13,696 worth of shares (3,261 units at $4.20) (SEC Form 4)

Frisch Scott M. bought $10,953 worth of shares (2,608 units at $4.20) (SEC Form 4)

Alpha Healthcare Acquisition Corp. III SEC Filings

Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Other Events, Financial Statements and Exhibits (Amendment)

Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Other Events, Financial Statements and Exhibits (Amendment)

Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

SEC Form NT 10-Q filed by Alpha Healthcare Acquisition Corp. III

SEC Form 8-K/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

Alpha Healthcare Acquisition Corp. III Press Releases

Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation

Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination

Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft Tissue Healing Indications

Alpha Healthcare Acquisition Corp. III Large Ownership Changes

SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

SEC Form SC 13G filed by Alpha Healthcare Acquisition Corp. III

SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

SEC Form SC 13G filed by Alpha Healthcare Acquisition Corp. III

SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

SEC Form SC 13G filed by Alpha Healthcare Acquisition Corp. III